This document describes a method for purifying target proteins from a mixture using cationic surfactants. The method involves exposing the protein mixture to an effective amount of cationic surfactant, which causes contaminating proteins to preferentially precipitate out of solution. The target protein is then recovered. The document provides details on the patent application, priority claims, inventors, classifications, and legal status information for patents granted in various contracting states.
This document describes a method for purifying target proteins from a mixture using cationic surfactants. The method involves exposing the protein mixture to an effective amount of cationic surfactant, which causes contaminating proteins to preferentially precipitate out of solution. The target protein is then recovered. The document provides details on the patent application, priority claims, inventors, classifications, and legal status information for patents granted in various contracting states.
This document describes a method for purifying target proteins from a mixture using cationic surfactants. The method involves exposing the protein mixture to an effective amount of cationic surfactant, which causes contaminating proteins to preferentially precipitate out of solution. The target protein is then recovered. The document provides details on the patent application, priority claims, inventors, classifications, and legal status information for patents granted in various contracting states.
Title (de) PROTEINAUFREININGUNG MIT HILFE VON KATIONISCHEN TENSIDEN Title (fr) PURIFICATION DE PROTINES AU MOYEN D'UN TENSIOACTIF CATIONIQUE Publication EP 2013225 B1 20141217 (EN) Application EP 06749952 A 20060412 Priority US 2006013751 W 20060412 Abstract (en) [origin: WO2008051178A2] The subject invention provides a method for purifying a target protein from a mixture comprising the target protein and contaminating protein, comprising the steps of exposing the mixture to an effective amount of a cationic surfactant such that the contaminating protein is preferentially precipitated and recovering the target protein. Proteins purified according to the method of the invention are also provided. Inventor FISCHER MEIR (IL) HAROSH ELIYAHU (IL) Applicant CREALTA PHARMACEUTICALS LLC (US) IPC 8 full level (invention and additional information) C07K 1/30 (2006.01) CPC (invention and additional information) C07K 1/30(2013.01) Designated contracting state (EPC) AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR EPO simple patent family WO 2008051178 A2 20080502; WO 2008051178 A3 20090507; CN 101622270 A 20100106; CN 101622270 B 20140101; EP 2013225 A2 20090114; EP 2013225 B1 20141217; ES 2532804 T3 20150331; HU 0800388 A2 20120730; IL 186514 D0 20110801; JP 2009533429 A 20090917; JP 5033177 B2 20120926; KR 101288027 B1 20130722; KR 20100116240 A 20101101; US 2009317889 A1 20091224 INPADOC legal status 2015-06-15 [REG AT MK05] REVOCATION OF THE TRANSLATION OF THE EP PATENT - Ref Country Code : AT - Ref Legal Event Code : MK05 - Ref Document Number : 701828 - Country of Ref Document : AT - Kind Code of Ref Document : T - Effective date : 20141217 2015-05-25 [REG LT MG4D] INVALIDATED EUROPEAN PATENT - Ref Country Code : LT - Ref Legal Event Code : MG4D 2015-04-30 [PG25 FI] LAPSED IN A CONTRACTING STATE ANNOUNCED VIA POSTGRANT INFORM. FROM NAT. OFFICE TO EPO - Ref Country Code : FI - Free Format Text : LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT - Effective date : 20141217 2015-04-30 [PG25 LT] LAPSED IN A CONTRACTING STATE ANNOUNCED VIA POSTGRANT INFORM. FROM NAT. OFFICE TO EPO - Ref Country Code : LT - Free Format Text : LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT - Effective date : 20141217 2015-03-31 [REG ES FG2A] DEFINITIVE PROTECTION - Ref Country Code : ES - Ref Legal Event Code : FG2A - Ref Document Number : 2532804 - Country of Ref Document : ES - Kind Code of Ref Document : T3 - Effective date : 20150331 2015-03-13 [REG CH NV] NEW AGENT
- Ref Country Code : CH
- Ref Legal Event Code : NV - Representative's name : BOVARD AG, CH 2015-01-29 [REG DE R096] DPMA PUBLICATION OF MENTIONED EP PATENT GRANT - Ref Country Code : DE - Ref Legal Event Code : R096 - Ref Document Number : 602006044022 - Country of Ref Document : DE - Effective date : 20150129 2015-01-15 [REG AT REF] REFERENCE TO AT NUMBER (EP PATENT ENTERS AUSTRIAN NATIONAL PHASE) - Ref Country Code : AT - Ref Legal Event Code : REF - Ref Document Number : 701828 - Country of Ref Document : AT - Kind Code of Ref Document : T - Effective date : 20150115 2015-01-14 [REG IE FG4D] EUROPEAN PATENTS GRANTED DESIGNATING IRELAND - Ref Country Code : IE - Ref Legal Event Code : FG4D 2014-12-31 [REG CH EP] ENTRY IN THE NATIONAL PHASE - Ref Country Code : CH - Ref Legal Event Code : EP 2014-12-17 [AK] DESIGNATED CONTRACTING STATES: - Kind Code of Ref Document : B1 - Designated State(s) : AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR 2014-12-17 [REG GB FG4D] EUROPEAN PATENT GRANTED - Ref Country Code : GB - Ref Legal Event Code : FG4D 2014-10-22 [INTG] ANNOUNCEMENT OF INTENTION TO GRANT - Effective date : 20140925 2014-10-22 [RIN1] INVENTOR (CORRECTION) - Inventor name : FISCHER, MEIR 2014-10-22 [RIN1] INVENTOR (CORRECTION) - Inventor name : HAROSH, ELIYAHU 2014-08-06 [RAP1] TRANSFER OF RIGHTS OF AN EP APPLICATION - Owner name : CREALTA PHARMACEUTICALS LLC 2012-07-25 [DAX] EXTENSION OF THE EUROPEAN PATENT TO (DELETED) 2011-05-11 [17Q] FIRST EXAMINATION REPORT - Effective date : 20110412 2009-09-11 [REG HK DE] REQUESTS TO DESIGNATE PATENT IN HONG KONG - Ref Country Code : HK - Ref Legal Event Code : DE - Ref Document Number : 1126794 - Country of Ref Document : HK 2009-06-10 [R17D] SEARCH REPORT (CORRECTION) - Effective date : 20090507 2009-02-18 [RIN1] INVENTOR (CORRECTION) - Inventor name : FISCHER, MEIR 2009-02-18 [RIN1] INVENTOR (CORRECTION) - Inventor name : HAROSH, ELIYAHU 2009-01-14 [17P] REQUEST FOR EXAMINATION FILED - Effective date : 20080717 2009-01-14 [AK] DESIGNATED CONTRACTING STATES: - Kind Code of Ref Document : A2 - Designated State(s) : AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2009-01-14 [AX] EXTENSION OR VALIDATION OF THE EUROPEAN PATENT TO